AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29231540
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (acupuncture at GV and Jiaji combined with rehabilitation training)
Trial: 23132445
Drug: Omega-3 oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 oral nutritional supplements (TheraTears Nutrition for Dry Eyes)
Trial: 14620923
Drug: Other antihypertensive
RxNorm normalized name: Other antihypertensives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antihypertensive agents (control)
Trial: 10906645
Drug: 10% glycolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glycolic acid gel, pH 3.52, applied once daily for 7 days and then twice daily for 2 weeks
Trial: 10906645
Drug: Placebo gel,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel, pH 5.75
Trial: 10906645
Drug: 10% glycolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% glycolic acid gel, pH 3.52
Trial: 1427582
Drug: Amikacin once
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin once daily plus metronidazole
Trial: 1427582
Drug: Amikacin twice
RxNorm normalized name: Amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin twice daily plus metronidazole
Trial: 6565300
Drug: Drug information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug information only
Trial: 6565300
Drug: Combined drug
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined drug and SEMT information
Trial: 27757142
Drug: Therapeutic educational
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic educational program in oral health (TEPOH)
Trial: 19099860
Drug: Midodrine hydrochloride
RxNorm normalized name: Midodrine Hydrochloride
DrugBank: Midodrine (DB00211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Midodrine hydrochloride and oral rehydration salt treatment
Trial: 19099860
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration salt treatment only
Trial: 16317760
Drug: IV EPO
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV EPO 600 IU/kg (max dose 40,000 IU) or placebo once weekly for 16 weeks, increased to 900 IU/kg (max dose 60,000 IU) if no response by week 3 or 4
Trial: 15048616
Drug: Moclobemide 150
RxNorm normalized name: moclobemide 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide 150 mg b.i.d. for 14 days
Trial: 7957792
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (200,000 IU, single oral dose)
Trial: 23951825
Drug: Elonza (generic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elonza (generic product of sildenafil) 100 mg taken as needed
Trial: 10636375
Drug: Maternal oral
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal oral zidovudine
Trial: 7488485
Drug: Thiopentone 6
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 6 mg kg‐1
Trial: 1827966
Drug: 16 mg
RxNorm normalized name: escin 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 mg oral ondansetron
Trial: 7302464
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of sodium aurothiomalate weekly
Trial: 7302464
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of sodium aurothiomalate weekly
Trial: 27698559
Drug: TURP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TURP plus tamsulosin hydrochloride 0.2 mg (TAM)
Trial: 27698559
Drug: TURP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TURP plus tamsulosin hydrochloride 0.2 mg (TAM) plus solifenacin succinate 5 mg (SOL)
Trial: 16337504
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg/day for 12 months
Trial: 16337504
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg/day for 3 months
Trial: 14620649
Drug: Nicotine patch/bupropion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch/bupropion group
Trial: 14620649
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch group
Trial: 10354218
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg of TNF-alpha plus 1 mg kg-1 melphalan (IHPTM group)
Trial: 10354218
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg kg-1 melphalan (IHPM group)
Trial: 8877260
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker (nisoldipine)
Trial: 16327016
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitor (enalapril)
Trial: 1757024
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg cefamandol administered intraocularly at the end of the operation
Trial: 1757024
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intraocularly at the end of the operation
Trial: 7113575
Drug: Chlorpropamide administration
RxNorm normalized name: Chlorpropamide
DrugBank: Chlorpropamide (DB00672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpropamide administration (CPAF test)
Trial: 7113575
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration instead of chlorpropamide
Trial: 30547820
Drug: Low-dose stavudine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose stavudine (20 mg twice daily)
Trial: 30547820
Drug: Tenofovir in
RxNorm normalized name: Product containing tenofovir in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir in combination with efavirenz and lamivudine
Trial: 30547820
Drug: Low-dose stavudine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose stavudine
Trial: 20394471
Drug: Levofloxacin 750
RxNorm normalized name: levofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 750 mg QD for 3 weeks
Trial: 20394471
Drug: Levofloxacin 750
RxNorm normalized name: levofloxacin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 750 mg QD for 2 weeks
Trial: 20394471
Drug: Levofloxacin 500
RxNorm normalized name: levofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin 500 mg QD for 4 weeks
Trial: 2327823
Drug: AIH with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIH with semen mixed with kallikrein (K, 5 IE/ml semen, n = 45)
Trial: 3433917
Drug: RA 27/3
RxNorm normalized name: Rubivirus rubella virus Wistar RA 27/3 whole
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RA 27/3 rubella vaccine
Trial: 7017582
Drug: Measles-mumps-rubella (RA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-mumps-rubella (RA 27/3) vaccine
Trial: 7017582
Drug: Combination vaccine
RxNorm normalized name: Hepatitis vaccine combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination vaccine incorporating HPV-77:DE-5 rubella
Trial: 7017582
Drug: Measles-mumps-rubella vaccines
RxNorm normalized name: MEASLES/MUMPS/RUBELLA VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles-mumps-rubella vaccines
Trial: 20182421
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of tacrolimus
Trial: 9052903
Drug: Xanomeline (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xanomeline (oral formulation)
Trial: 9052903
Drug: Xanomeline (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xanomeline (first dose)
Trial: 8306902
Drug: Hydroflumethiazide (HFM)
RxNorm normalized name: Hydroflumethiazide
DrugBank: Hydroflumethiazide (DB00774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroflumethiazide (HFM) 50mg daily
Trial: 8306902
Drug: Propranolol 80mg
RxNorm normalized name: HCTZ 25/PROPRANOLOL 80MG TAB
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol 80mg daily
Trial: 8306902
Drug: Propranolol 160mg
RxNorm normalized name: HCTZ 50/PROPRANOLOL 160MG SA CAP
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol 160mg daily (after 4 weeks)
Trial: 30893577
Drug: MRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRA therapy (intravenous bolus of potassium canrenoate followed by oral spironolactone for 3 months)
Trial: 30893577
Drug: MRA therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRA therapy
Trial: 29183291
Drug: Hockey Fans
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hockey Fans in Training (Hockey FIT) program, 90-minute weekly sessions for 12 weeks followed by a 40-week minimally-supported phase.
Trial: 26085531
Drug: Twenty-four-hour group
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twenty-four-hour group (received perioperative antibiotics for twenty-four hours)
Trial: 26085531
Drug: Drain-duration group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drain-duration group (received antibiotics for the duration that the drain was in place)
Trial: 15218999
Drug: BA+ICS (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BA+ICS (0.2 mg salbutamol t.i.d. and 0.2 mg budesonide t.i.d.)
Trial: 10899363
Drug: d-amphetamine (AMPH;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (AMPH; 15 mg oral)
Trial: 9270499
Drug: Newer antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Newer antimicrobial agents (third- and fourth-generation cephalosporins, β-lactam, β-lactamase inhibitor combination agents, monobactams, carbapenems, macrolides, fluoroquinolones)
Trial: 9270499
Drug: Older antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older antimicrobial agents
Trial: 3089942
Drug: Oral penicillin
RxNorm normalized name: penicillin G Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral penicillin V‐K (100,000 U/kg/day every 6 h)
Trial: 29932415
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) injection (2 mL)
Trial: 29932415
Drug: Procaine injection
RxNorm normalized name: Procaine Injection Oil
DrugBank: Procaine (DB00721)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Procaine injection
Trial: 26149510
Drug: ADHD medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADHD medications (stimulant or nonstimulant)
Trial: 26149510
Drug: No ADHD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ADHD medications (control group)
Trial: 23086673
Drug: Conventional hypervolemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional hypervolemic therapy (HT)
Trial: 16575034
Drug: Midazolam (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.05 mg x kg(‐1))
Trial: 16575034
Drug: Aminophylline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (3 mg.kg(‐1))
Trial: 15198411
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg plus dexamethasone 8 mg
Trial: 3052571
Drug: CSII and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSII and MI (intensified treatment)
Trial: 31122650
Drug: Pre-learning propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-learning propranolol (40 mg)
Trial: 31122650
Drug: Post-learning propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-learning propranolol (40 mg)
Trial: 31122650
Drug: Pre-encoding propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-encoding propranolol (40 mg) in women
Trial: 28207655
Drug: Standard-dose C-arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose C-arm fluoroscopy
Trial: 23624059
Drug: Oral source
RxNorm normalized name: AMYLOPECTIN, UNSPECIFIED SOURCE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral source of glucose (juice) during reconsolidation
Trial: 19023522
Drug: Heparin used
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin used in 26% of patients
Trial: 7594429
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amlodipine and doxazosin (study A)
Trial: 7594429
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amlodipine and enalapril (study B)
Trial: 2253658
Drug: Furosemide 20
RxNorm normalized name: furosemide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 20 mg injected intravenously
Trial: 7011279
Drug: Cimetidine (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (1.0 g/day initially, increased to 1.6 g/day if less than 50% reduction in ulcer size)
Trial: 7011279
Drug: Cimetidine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (600 mg/day)
Trial: 7011279
Drug: Cimetidine (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (after stopping maintenance treatment)
Trial: 30924166
Drug: Furosemide 20
RxNorm normalized name: furosemide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 20 mg intravenously
Trial: 28347540
Drug: Sivelestat administered
RxNorm normalized name: Sivelestat
DrugBank: Sivelestat (DB12863)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sivelestat administered perioperatively for 5 days
Trial: 28347540
Drug: No medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medications administered (Control group)
Trial: 25864870
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D + omega-3 PUFA (30 µg vitamin D3, 3000 mg eicosapentaenoic acid, 3000 mg docosahexaenoic acid)
Trial: 21156702
Drug: 5-fluorouracil and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil and low-molecular-weight heparin
Trial: 19717506
Drug: Low-frequency sound
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency sound wave therapy, 3-5 times a week for 30 minutes per session over 6 months
Trial: 19717506
Drug: Low-frequency sound
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-frequency sound wave therapy
Trial: 17451140
Drug: Antihypertensive drugs,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive drugs, specifically blockers of the renin-angiotensin axis
Trial: 8313326
Drug: Conservative surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative surgery plus radiation therapy
Trial: 3046826
Drug: Piroxicam, 20
RxNorm normalized name: Piroxicam, 20 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam, 20 mg per day
Trial: 3046826
Drug: Naproxen, 750
RxNorm normalized name: Naproxen, 750 mg (as sodium) oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 750 mg per day
Trial: 29687457
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT), 10-session manualized intervention
Trial: 23692516
Drug: ICA-105665 100
RxNorm normalized name: ICA-105665
DrugBank: ICA-105665 (DB06089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICA-105665 100 mg
Trial: 23692516
Drug: ICA-105665 400
RxNorm normalized name: ICA-105665
DrugBank: ICA-105665 (DB06089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICA-105665 400 mg
Trial: 23692516
Drug: ICA-105665 500
RxNorm normalized name: ICA-105665
DrugBank: ICA-105665 (DB06089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICA-105665 500 mg
Trial: 20697044
Drug: 450 or
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 or 900 mg of idebenone per day (n = 22)
Trial: 20697044
Drug: 1350 or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1350 or 2250 mg of idebenone per day (n = 24)
Trial: 10807098
Drug: Hyaluronan injections
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronan injections
Trial: 9387366
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at Zusanli (ST 36) and Neiguan (PC 6) combined with epidural anesthesia of small dosage (group A)
Trial: 9387366
Drug: Simple epidural
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple epidural anesthesia of small dosage (group B)
Trial: 15374380
Drug: Amantadine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine (200 mg for 1 h)
Trial: 3881014
Drug: Cimetidine 1800
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 1800 mg/day
Trial: 3881014
Drug: Sucralfate 8
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate 8 g/day
Trial: 30585829
Drug: Platelet decrease
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet decrease following renal replacement therapy initiation
Trial: 26197029
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of terbutaline (TER)
Trial: 17227746
Drug: Homeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic treatment (optimal medication identified after screening phase)
Trial: 17227746
Drug: Homeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic treatment (optimal medication identified)
Trial: 15176988
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg daily plus elemental calcium 500 mg daily
Trial: 15176988
Drug: Calcium 500
RxNorm normalized name: Calcium 500+D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 500 mg daily alone
Trial: 9839093
Drug: Acarbose (25-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (25-100 mg t.i.d.)
Trial: 2543048
Drug: New less
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New less toxic treatment
Trial: 24075291
Drug: Lawton‐Brady activities
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lawton‐Brady activities of daily living (ADL) scale
Trial: 21169060
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus cetuximab with first-cycle rash
Trial: 21169060
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus cetuximab without first-cycle rash
Trial: 11107075
Drug: PTFE Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTFE Patch Closure
Trial: 11107075
Drug: PTFE Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTFE Patch Closure and Vein Patch Closure (VPC)
Trial: 2989349
Drug: Enalapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (5 to 10 mg orally)
Trial: 2989349
Drug: Enalapril (long-term
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (long-term treatment)
Trial: 20974575
Drug: Raltegravir 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir 800 mg once daily
Trial: 20974575
Drug: Raltegravir twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir twice daily for 3 months then once daily
Trial: 17017631
Drug: Liquid whitening
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid whitening gel (5.9% hydrogen peroxide, twice a day for 15 minutes)
Trial: 17017631
Drug: Sodium chlorite‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium chlorite‐based whitening gel applied in a tray system (10 minutes twice a day)
Trial: 2860739
Drug: STA‐MCA bypass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STA‐MCA bypass in addition to medical therapy (daily aspirin and aggressive hypertension control)
Trial: 2860739
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment alone (daily aspirin and aggressive hypertension control)
Trial: 28625036
Drug: Sago worm
RxNorm normalized name: Worm Protector 2X
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sago worm inclusive diet (100 g per day for 45 days)
Trial: 26309676
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of deep-breathing exercises and oxygen inhalation